1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine has been researched along with cyclohexene in 1 studies
| Studies (1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine) | Trials (1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine) | Recent Studies (post-2010) (1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine) | Studies (cyclohexene) | Trials (cyclohexene) | Recent Studies (post-2010) (cyclohexene) |
|---|---|---|---|---|---|
| 14 | 1 | 0 | 204 | 1 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caprathe, BW; Downing, DM; Glase, SA; Heffner, TG; Jaen, JC; Johnson, SJ; Kesten, SR; MacKenzie, RG; Meltzer, LT; Wright, JL | 1 |
1 other study(ies) available for 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine and cyclohexene
| Article | Year |
|---|---|
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antipsychotic Agents; Avoidance Learning; Brain; CHO Cells; Cricetinae; Crystallography, X-Ray; Cyclic AMP; Cyclohexanes; Cyclohexenes; Dopamine; Dopamine Agonists; Mice; Models, Molecular; Molecular Structure; Motor Activity; Pyridines; Rats; Receptors, Dopamine; Saimiri; Stereoisomerism; Structure-Activity Relationship; Substantia Nigra | 1994 |